Quanzhen Medical secures 100 million yuan in Series B financing

Quanzhen Medicine, an innovative enterprise in the field of medical large models, announced the completion of a 100 million yuan Series B financing round. This round of financing includes a strategic investment completed by A-share listed company Innovation Medical in the fourth quarter of 2024, and a Series B investment completed by Good Doctor Group in the second quarter of 2025. Probe Capital served as the exclusive financial advisor for this round of financing. After this round of financing, Quanzhen Medicine will continue to increase R & D investment, upgrade the personal doctor version of Quanzhentong and improve the performance of the Quanzhen Medicine large model, providing more comprehensive and professional AI support for doctors and hospitals, such as clinical research assistance (medical record collection, organization and follow - up), competency training (AI - assisted learning, virtual patients), and clinical decision - making support (literature/guideline retrieval and summarization).